Month: May 2024

EEZY PLC —   INTERIM REPORT   — 7 MAY 2024 AT 8:00 Eezy Plc’s Interim Report 1–3/2024: Demand for staffing services remains weak – focus on increasing productivity January–March 2024Revenue was EUR 41.5 million (EUR 52.8 million in January–March 2023). Revenue decreased by 21%. EBITDA was EUR 2.3 million (3.4). EBIT was EUR 0.5 million (1.3) and was 1.2% of revenue (2.5%). EUR 0.3 million in personnel expenses related to severance payments were recorded in the result. Earnings per share was EUR 0.01 (0.02).Outlook for 2024 Eezy does not give guidance for 2024. Key figures (IFRS)EUR million, unless otherwise specified 1–3/2024 1–3/2023 1–12/2023Revenue 41.5 52.8 219.0EBITDA 2.3 3.4 14.5EBITDA, % 5.5% 6.5% 6.6%EBIT 0.5 1.3 4.0EBIT, % 1.2% 2.5% 1.8%EPS, basic, EUR 0.01 0.02 0.03EPS, diluted,...

Aspo Plc Interim Report               May 7, 2024, at 8:00 am Aspo Group Interim Report, January 1 – March 31, 2024 Successful strategy execution in a challenging operating environment Figures from the corresponding period in 2023 are presented in brackets. January–March 2024Net sales from continuing operations decreased to EUR 132.7 (141.6) million. Comparable operating profit from continuing operations was EUR 4.8 (8.4) million, 3.6% (5.9%) of net sales. The comparable operating profit of ESL Shipping was EUR 2.7 (6.0) million, Telko EUR 2.2 (2.7) million, and Leipurin EUR 1.1 (1.0) million. Operating profit from continuing operations was EUR -3.2 (8.6) million, -2.4% (6.1%) of net sales. Operating profit of ESL Shipping was EUR -5.0 (6.0) million, Telko EUR 2.2 (2.7) million, and Leipurin EUR 1.1 (1.2) million. Items affecting...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASEStrong first quarter performance, with net sales [1] of USD 2.5 billion, up 6% in constant currencies (up 5% in USD) Biosimilar business growing 21% in constant currencies  All regions contributing to growth Acquisition of CIMERLI® (ranibizumab-eqrn) completed in March 2024Basel, May 7, 2024 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced net sales for the first quarter 2024. Net sales were USD 2.5 billion, an increase of 6% in constant currencies compared to the same quarter of the prior year. Biosimilars saw another quarter of double-digit net sales growth, an increase of 21% in constant currencies. Generics sales remained in line with prior year levels. Richard Saynor, Chief Executive Officer...

  Trifork Group – Interim report for the quarter ending 31 March 2024 Company announcement no. 25 / 2024Schindellegi, Switzerland – 7 May 2024 Trifork Group reports Q1 revenue growth of 1.4% impacted by fewer working days First quarter 2024Trifork GroupIn Q1 2024, Trifork Group revenue amounted to EURm 50.4, an increase of 1.4% from Q1 2023. The quarter was impacted by fewer business days in the quarter due to the Easter break being in March instead of April as in the past years. The effect of this is estimated to EURm 2.8 (5.6%) in Q1 2024 compared to Q1 2023. Trifork Group EBITDA amounted to EURm 5.3, corresponding to 10.5% EBITDA margin. The timing of Easter and one-off cost from reorganizations are estimated to affect EBITDA negatively by EURm 2.5 in the quarter. Trifork Group EBIT amounted to EURm 1.4, corresponding to...

Highlights Q1 2024Positive momentum in PC continued, with an 80-percent year-on-year growth Slight increase in gross margin compared to the previous quarter, as profitability in non-Mobile areas continues to be strong Continued execution of cost optimization program, with a nine-percent reduction in the number of employees since the end of 2023Post-Q1 2024By winding down the loss-making operations in Mobile, we will have a focused and profitable growth business Announced partially guaranteed rights issue of up to approximately SEK 310 million, strengthening balance sheet by reducing debt and increasing equity through an early repayment of outstanding convertible bondsFirst quarter of 2024Revenues amounted to SEK 146.4 M (117.0) The gross margin was 11.1 percent (17.3) EBITDA amounted to negative SEK 50.5 M (neg: 60.2) Adjusted...

KH Group Plc Stock Exchange Release 7 May 2024 at 8.00 am EEST KH Group Plc’s Business Review January–March 2024: Focus on business profitability This is the summary of the Business Review for January–March 2024. The full Half-Year Report is attached to this release and is also available on the company’s website at www.khgroup.com. KH Group, January–March 2024 pro forma Net sales amounted to EUR 84.2 (100.2) million. Operating profit was EUR -0.3 (1.0) million. KH-Koneet’s net sales and operating profit decreased considerably year-on-year. Indoor Group’s net sales decreased significantly. Operating profit, including the capital gain of EUR 3.7 million from the Estonian real estate sale transaction, was higher than in the comparison period. HTJ’s net sales were at the same level as in the comparison period but operating profit decreased. NRG’s...

ANCHORAGE, Alaska, May 06, 2024 (GLOBE NEWSWIRE) — First National Bank Alaska’s (OTCQX:FBAK) net income for the first quarter of 2024 remained stable at $13.476 million, or $4.26 per share. This compares to a net income of $13.454 million, or $4.25 per share, for the same period in 2023. “Positive signs across sectors of the Alaska economy give First National an optimistic outlook for growth in the coming year, as evident in first quarter lending activity,” said Betsy Lawer, First National Board Chair and CEO/President. “Our lending, treasury management services, and wealth management and trust* relationship officers are all working closely with customers as seasonal activity builds momentum.” Assets totaled $5.2 billion as of March 31, 2024, decreasing $517.9 million since December 31, 2023. The decrease in assets was primarily...

(All monetary references are expressed in Canadian dollars, unless otherwise indicated) MONTREAL, May 06, 2024 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) reports its financial and operating results for the three months ended March 31, 2024 (“Q1 2024“). Q1 2024 HIGHLIGHTS Operating, Financial and Corporate Updates:619 ounces of gold sold by the Company from operating activities in the first quarter, comprising of 585 ounces of gold sold from the Trixie test mine (“Trixie“), and the balance from the Cariboo Gold Project (“Cariboo Gold Project“) by processing stockpiles at a third-party processing facility. $1.8 million in revenues ($3.5 million in Q1 2023) and $2.0 million in cost of sales ($4.4 million in...